Risk for Prolonged Use With Tramadol vs Other Short-Acting Opioids Examined
Compared with other short acting opioids, patients prescribed tramadol may be at greater risk of prolonged use following surgery, according to a study published in The BMJ.
All articles by Diana Ernst, RPh
Injectable Pain Med Recalled Due to Possible Microbial Contamination
A recall of 1 lot of Ketorolac Tromethamine Injection 60mg/2mL (30mg/mL) has been initiated by Sagent Pharmaceuticals following the discovery of microbial growth during a routine simulation of the manufacturing process. Concerns over the possible introduction of microorganisms into the product led the Company to issue the recall to the user level. The product is…
Fremanezumab Cluster Headache Development Program Discontinued
Teva announced that the ENFORCE phase 3 program for fremanezumab in the treatment of cluster headaches will be discontinued following results from a futility analysis.
FDA to Review IV-Administered Eptinezumab for Migraine Prevention
The FDA has accepted for review the Biologics License Application for eptinezumab (Alder BioPharmaceuticals), an investigational CGRP inhibitor for migraine prevention.
FDA Updates REMS for Transmucosal Immediate-Release Fentanyl Products
The Food and Drug Administration has announced that the Risk Evaluation and Mitigation Strategy (REMS) for transmucosal immediate-release fentanyl (TIRF) medications has been updated to better ensure the safe use of these products.
Oncology Split-Fill Program May Help Improve Adherence, Cut Costs and Reduce Medication Waste
A study presented at the Academy of Managed Care Pharmacy Managed Care and Specialty Pharmacy 2019 Annual Meeting showed that an oral oncology split-fill program implemented by AllianceRx Walgreens Prime resulted in improved adherence and reduced pharmacy costs and medication waste.
Authorized Generic of Flector Patch Now Available From Teva
An authorized generic of Flector Patch (diclofenac epolamine topical patch) has been made available by Teva Pharmaceuticals for the topical treatment of acute pain due to minor strains, sprains, and contusions.
FDA Issues Contraindications, Warnings on Codeine, Tramadol Use
The FDA is restricting the use of codeine and tramadol medicines in children.
Opioid Prescribing Guidelines for Chronic, Non-Cancer Pain
The American Society of Interventional Pain Physicians (ASIPP) has issued updated opioid prescribing guidelines for the management of patients with chronic, non-cancer pain.
Variety of Factors Limit Clinicians Willingness to Prescribe Naloxone
A variety of factors may limit clinician willingness to prescribe naloxone, a potentially life-saving medication that counteracts the effects of opioid overdose.
